Unique ID issued by UMIN | UMIN000002361 |
---|---|
Receipt number | R000002893 |
Scientific Title | Phase II study of modified S-1, docetaxel and cisplatin combination chemotherapy (mDCS) in patients with unresectable metastatic gastric cancer. |
Date of disclosure of the study information | 2009/10/01 |
Last modified on | 2015/01/30 17:05:53 |
Phase II study of modified S-1, docetaxel and cisplatin combination chemotherapy (mDCS) in patients with unresectable metastatic gastric cancer.
Phase II study of mDCS for unresectable metastatic gastric cancer
Phase II study of modified S-1, docetaxel and cisplatin combination chemotherapy (mDCS) in patients with unresectable metastatic gastric cancer.
Phase II study of mDCS for unresectable metastatic gastric cancer
Japan |
Gastric cancer
Gastroenterology |
Malignancy
NO
To investigate efficacy of modified DCS (docetaxel 50mg/m2, CDDP 60mg/m2, TS-1 80mg/m2) for unresectable metastatic gastric cancer
Safety,Efficacy
Phase II
Response rate
Overall survival, progression free survival, time to response, duration of response, safety
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Medicine |
Treatment with docetaxel+Cisplatin+S-1 combination chemotherapy.
Docetaxel 50mg/m2 iv (d8), Cisplatin 60mg/m2 iv (d8), S-1 80mg/m2 po (BID) (d1-14)
20 | years-old | <= |
80 | years-old | > |
Male and Female
1)Written informed consent.
2)Histologicaly (cytologically) proven gastric cancer.
3)Unresectable gastric cancer.
4)To have measurable lesions.
5)No prior chemotherapy or no influence of prior therapy.
6)Tolerable function of bone marrow, liver and kidney.
7)PS 0 - 1.
8)Expected survival for 3 months.
9)Possible oral intake.
1)History of hypersensitivity to DCS.
2)Contraindication to TXT, CDDP, S-1, G-CSF.
3)Infectious disease.
4)Severe compliaction.
5)Neuropathy greater than grade 2.
6)Brain metastasis with clinical symptoms.
7)Watery diarea.
8)Active double cancer.
9)Persons to be pregnant or to make pregnant.
50
1st name | |
Middle name | |
Last name | Tetsuji Takayama |
Tokushima University Hospital.
Department of Gastroenterology
3-18-15, Kuramoto-cho, Tokushima city
0886337124
takayama@clin.med.tokushima-u.ac.jp
1st name | |
Middle name | |
Last name | Tetsuji Takayama |
Tokushima University Hospital.
Department of Gastroenterology
3-18-15, Kuramoto-cho, Tokushima
0886337124
takayama@clin.med.tokushima-u.ac.jp
Tokushima-Hokkaido cancer therapy clinical trial group
Self-funding
Self funding
NO
2009 | Year | 10 | Month | 01 | Day |
Unpublished
Open public recruiting
2009 | Year | 09 | Month | 18 | Day |
2010 | Year | 05 | Month | 01 | Day |
2013 | Year | 03 | Month | 01 | Day |
2009 | Year | 08 | Month | 21 | Day |
2015 | Year | 01 | Month | 30 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000002893